Background and Study Aims: Endoscopic microtransducer manometry of the sphincter of Oddi has been shown to be
a reliable alternative to perfusion manometry for evaluating sphincter of Oddi motor
function. It avoids volume loading of the biliopancreatic system, and may therefore
be associated with a lower risk of inducing postmanometry pancreatitis.
Patients and Methods: During a 2-year period, microtransducer manometry of the sphincter of Oddi was carried
out in 215 patients (median age 42 years; 155 women; biliary study in 152 cases, additional
pancreatic evaluation in 63 cases). Sphincter of Oddi manometry was conducted as the
sole procedure in all patients. The frequency of pancreatitis was assessed prospectively
and graded according to established guidelines. A total of 130 consecutive patients
(median age 37 years, 92 women; 30 with biliary type II, 58 with type III, 34 with
pancreatic type I, and eight with type II) were then randomly assigned to undergo
microtransducer or perfusion manometry of the sphincter of Oddi in a standardized
fashion.
Results: During the initial 2-year period, nine cases of pancreatitis (a pancreatitis frequency
of 4.2 %) were observed after microtransducer manometry, and most were of mild degree
(six mild, two moderate, and one severe). No deaths occurred, and no surgical procedures
were required. In the randomized part of the study, the demographic and clinical characteristics
of the patients in both groups, as well as the technical aspects of the procedures
performed, were well matched. The frequency of pancreatitis after microtransducer
manometry was 3.1 %, compared with 13.8 % after perfusion manometry (P < 0.05). Pancreatitis occurred in two patients after microtransducer manometry, and
was mild in both cases. After perfusion manometry, mild pancreatitis occurred in six
patients and moderate pancreatitis in three.
Conclusion: Endoscopic microtransducer manometry of the sphincter of Oddi is associated with
a lower risk for postmanometry pancreatitis than standard perfusion manometry.
References
1
Albert M B, Steinberg W M, Irani S K.
Severe acute pancreatitis complicating sphincter of Oddi manometry.
Gastrointest Endosc.
1988;
34
342-345
2
King C E, Kalvaria I, Suinsky C A.
Pancreatitis due to endoscopic biliary manometry: proceed with caution [abstract].
Gastroenterology.
1988;
94
227
3
Rolny P, Anderberg B, Ihse I, Olaison G, Arvill A.
Pancreatitis after sphincter of Oddi manometry.
Gut.
1990;
31
821-824
4
Scicchitano J, Saccone G T, Baker R A, Roberts-Thomson I C, Toouli J.
How safe is endoscopic sphincter of Oddi manometry?.
J Gastroenterol Hepatol.
1995;
10
334-336
5
Wehrmann T, Wendler O G, Jung M, Caspary W F.
Risk factors of endoscopic manometry in patients with suspected sphincter of Oddi
dysfunction.
Dtsch Med Wochenschr.
1997;
122
808-814
6
Maldonado M E, Brady P G, Mamel J J, Robinson B.
Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry.
Am J Gastroenterol.
1999;
94
387-390
7
Freeman M L, Nelson D B, Sherman S. et al .
Complications of endoscopic biliary sphincterotomy.
N Engl J Med.
1996;
335
909-918
8
Freeman M L, DiSario J A, Nelson D B. et al .
Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.
Gastrointest Endosc.
2001;
54
425-434
9
Mehta S N, Pavone E, Barkun J S, Bouchard S, Barkun A N.
Predictors of post-ERCP complications in patients with suspected choledocholithiasis.
Endoscopy.
1998;
30
457-463
10
Trap R, Adamsen S, Hart-Hansen O, Henriksen M.
Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective
series of claims to insurance covering public hospitals.
Endoscopy.
1999;
31
125-130
11
Meshkinpour H, Kay L, Mollot M.
The role of the flow-rate of the pneumohydraulic system on post-sphincter of Oddi
manometry.
J Clin Gastroenterol.
1992;
14
236-239
12
Sherman S, Troiano F P, Hawes R H. et al .
Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a
modified aspirating catheter.
Gastrointest Endosc.
1990;
36
462-466
13
Sherman S, Hawes R H, Troiano F P, Lehman G A.
Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating
catheter.
Gastrointest Endosc.
1992;
38
347-350
14
Vondrasek P, Eberhardt G, Classen M.
Endoscopic semiconductor manometry.
Int J Med.
1974;
3
188-192
15
Tanaka M, Ikeda S.
Sphincter of Oddi manometry: comparison of microtransducer and perfusion methods.
Endoscopy.
1988;
20 (Suppl. 1)
184-188
16
Tanaka M, Ikeda S, Nakayama F.
Continuous measurement of common bile duct pressure with an indwelling microtransducer
catheter introduced by duodenoscopy: new diagnostic aid for post-cholecystectomy dyskinesia
- a preliminary report.
Gastrointest Endosc.
1983;
29
83-86
17
Tanaka M, Ikeda S, Nakayama F.
Nonoperative measurement of pancreatic and common bile duct pressure with a microtransducer
catheter and effects of duodenoscopic sphincterotomy.
Dig Dis Sci.
1981;
26
545-552
18
Ochi T, Nakazawa S, Naito Y, Tsukamoto Y.
Endoscopic manometry of the sphincter of Oddi and pancreatic duct in patients with
papillary stenosis.
Endoscopy.
1991;
23
255-258
19
Laugier R.
Dynamic endoscopic manometry of the response to secretin in patients with chronic
pancreatitis.
Endoscopy.
1994;
26
222-227
20
Wehrmann T, Schmitt T, Schönfeld A, Caspary W F, Seifert H.
Endoscopic sphincter of Oddi manometry with a portable electronic microtransducer
system: comparison with the perfusion manometry method and routine clinical application.
Endoscopy.
2000;
32
444-451
21
Goff J S.
Effect of propofol on human sphincter of Oddi.
Dig Dis Sci.
1995;
40
2364-2367
22
Schmitt T, Seifert H, Dietrich C F, Caspary W F, Wehrmann T.
Sedation with propofol during endoscopic sphincter of Oddi manometry.
Z Gastroenterol.
1999;
37
219-227
23
Wehrmann T, Lembcke B, Caspary W F, Seifert H.
Intravenous sedation with propofol during routine ERCP: a prospective, randomized
trial.
Gastrointest Endosc.
1999;
49
677-683
24
Cotton P B, Lehman G A, Vennes J. et al .
Endoscopic sphincterotomy complications and their management: an attempt at consensus.
Gastrointest Endosc.
1991;
37
383-393
25
Wehrmann T, Marek S, Hanisch E, Lembcke B, Caspary W F.
Causes and management of recurrent biliary pain after successful nonoperative gallstone
treatment.
Am J Gastroenterol.
1997;
92
132-138
26
Sherman S, Lehman G A.
ERCP- and endoscopic sphincterotomy-induced pancreatitis.
Pancreas.
1991;
6
350-367
27
Gottlieb K, Sherman S.
ERCP and endoscopic biliary sphincterotomy-induced pancreatitis.
Gastrointest Endosc Clin N Am.
1998;
8
87-114
28
Johnson G K, Geenen J E, Johanson J F. et al .
Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study
of differing contrast media.
Gastrointest Endosc.
1997;
46
217-222
29
Rabenstein T, Schneider H T, Bulling D. et al .
Analysis of risk factors associated with endoscopic sphincterotomy techniques: preliminary
results of a prospective study, with emphasis on the reduced risk of acute pancreatitis
with low-dose anticoagulation treatment.
Endoscopy.
2000;
32
10-19
30
Loperfido S, Angelini G, Benedetti G. et al .
Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter
study.
Gastrointest Endosc.
1998;
48
1-10
31
Dickinson R J, Davies S.
Post-ERCP pancreatitis and hyperamylasaemia: the role of operative and patient.
Eur J Gastroenterol Hepatol.
1998;
10
423-428
32
Kozarek R A.
Biliary dyskinesia: are we any closer to defining the entity?.
Gastrointest Endosc Clin N Am.
1993;
3
167-178
33
Steinberg W M.
Sphincter of Oddi dysfunction: a clinical controversy.
Gastroenterology.
1988;
95
1409-1415
34
Wehrmann T, Seifert H, Hagenmüller F, Jung M, Caspary W F.
Endoscopic sphincter of Oddi manometry: does scepticism vanish.
Z Gastroenterol.
1996;
34
17-25
35
Clouse R E, Staiano A, Alrakawi A, Haroian L.
Application of topographical methods to clinical esophageal manometry.
Am J Gastroenterol.
2000;
95
2720-2730
36
Ponchon T, Pilleul F.
Diagnostic ERCP.
Endoscopy.
2002;
34
29-42
37
Christoforidis E, Goulimaris I, Kanellos I. et al .
Post-ERCP pancreatitis and hyperamylasaemia: patient-related and operative risk factors.
Endoscopy.
2002;
34
286-292
T. Wehrmann, M.D.
Dept. of Internal Medicine I
Klinikum Hannover-Siloah · Roesebeckstrasse 15 · 30449 Hannover · Germany
Fax: + 49-511-9272669
Email: twehrmann@hotmail.com